GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Circio Holding ASA (OSL:CRNA) » Definitions » 3-Year FCF Growth Rate

Circio Holding ASA (OSL:CRNA) 3-Year FCF Growth Rate : 32.70% (As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Circio Holding ASA 3-Year FCF Growth Rate?

Circio Holding ASA's Free Cash Flow per Share for the three months ended in Dec. 2023 was kr0.00.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was 32.70% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 45.00% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was 15.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.

During the past 12 years, the highest 3-Year average Free Cash Flow per Share Growth Rate of Circio Holding ASA was 78.10% per year. The lowest was -116.20% per year. And the median was 9.10% per year.


Competitive Comparison of Circio Holding ASA's 3-Year FCF Growth Rate

For the Biotechnology subindustry, Circio Holding ASA's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Circio Holding ASA's 3-Year FCF Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Circio Holding ASA's 3-Year FCF Growth Rate distribution charts can be found below:

* The bar in red indicates where Circio Holding ASA's 3-Year FCF Growth Rate falls into.



Circio Holding ASA 3-Year FCF Growth Rate Calculation

This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.


Circio Holding ASA  (OSL:CRNA) 3-Year FCF Growth Rate Explanation

Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.


Circio Holding ASA 3-Year FCF Growth Rate Related Terms

Thank you for viewing the detailed overview of Circio Holding ASA's 3-Year FCF Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Circio Holding ASA (OSL:CRNA) Business Description

Traded in Other Exchanges
Address
Vollsveien 19, Lysaker, Oslo, NOR, 1366
Circio Holding ASA is a clinical-stage company. It is focused on developing and commercializing immuno-oncology therapies to target treatment-resistant solid tumors. Its product candidate, ONCOS-102, is a genetically modified oncolytic adenovirus, which has been engineered to infect cancer cells and activate the immune system to fight cancer. It includes the development and implementation with the purpose of developing targeted immunotherapy treatments for cancer patients.

Circio Holding ASA (OSL:CRNA) Headlines

No Headlines